Abbott Laboratories (ABT) Revenue — Quarter Ended Sep 30, 2023
Revenue for the quarter was essentially flat compared to the prior quarter, but declined relative to the same quarter last year. The sequential trend shows a slight uptick after a dip in the preceding period.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue for the quarter was essentially flat compared to the prior quarter, but declined relative to the same quarter last year. The sequential trend shows a slight uptick after a dip in the preceding period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$10.1B
Revenue reported for this quarter.
Quarter-over-quarter
+1.7%
Change from the immediately preceding quarter.
Year-over-year
-2.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$40B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $10.1B | -12.0% |
| Mar 31, 2023 | $9.7B | -18.1% |
| Jun 30, 2023 | $10B | -11.4% |
| Sep 30, 2023 | $10.1B | -2.6% |
Revenue performance
Reported revenue moved higher from the immediately preceding quarter, reversing a prior decline. However, compared with the same quarter one year earlier, revenue was lower.
Quarterly comparison
Revenue increased slightly from the prior quarter, but decreased from the year-ago period. The trailing twelve-month revenue figure remained unchanged from the current quarter's level.
What to watch
The filing context does not provide specific revenue drivers; monitor future filings for underlying factors behind the year-over-year decline.